Grifols Sa Revenue per Employee (GRFS), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Grifols Sa  (NASDAQ: GRFS)
 

Grifols Sa's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 4.32% in the fourth quarter 2025, year on year to cumulative value of $8,427 million, Grifols Sa's revenue per employee grew on a trailing twelve months basis to $ 2,622,745, this marks a new company high.
Within the Healthcare sector Employees of 28 other companies have achieved higher revenue per employee. While Grifols Sa's total ranking has deteriorated compared to the previous quarter from 0 to 407. Grifols Sa has 3,213 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GRFS Revenue per Employee (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Revenue Change 4.32 % - - - -
Sales per Employee (TTM) $ 2,622,745 2,514,120 2,514,120 2,514,120 2,514,120
GRFS's Total Ranking # 407 # 0 # # #
Seq. Revenue Change - - - - -

GRFS Company Profile >> Back to GRFS Efficiency Comparisons >> Compare GRFS Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 18
Healthcare Sector # 29
Overall Market # 407

Revenue per Employee Statistics
High Average Low
$ 2,622,745 $ 2,568,433 $ 2,514,120
(Dec 31 2025)   (Dec 31 2024)



Financial Statements
Grifols Sa's Revenue MRQ $ 8,427 Millions Visit GRFS's Income Statement
Grifols Sa's Revenues TTM $ 8,427 Millions Visit GRFS's aggregate revenue growth
What are GRFS's Sales? Visit GRFS's Sales by Segment




Other Ratios
Grifols Sa's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
GRFS's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for GRFS's Competitors
Revenue per Employee for GRFS's Suppliers
Revenue per Employee for GRFS's Customers

You may also want to know
GRFS's Sales Growth Rates GRFS's Pe Price to earnings ratio GRFS's Receivables Turnover Ratio GRFS's Stock Quote
GRFS's Net Income Growth Rates GRFS's Ps Price to Sales ratio GRFS's Sales per Employee GRFS's Asset Turnover Ratio
GRFS's Net Margin GRFS's Pb Price to Book ratio GRFS's Financial Strength Ratios GRFS's Dividend Payout Ratio
Date modified: 2026-06-22T16:58:57+00:00




Companies with similar Revenue per Employee for 12 months ending Dec 31 2025, within Healthcare Sector Revenue per Employee Revenue 12 months ending Dec 31 2025Number of Employees Dec 31 2025
P3 Health Partners Inc   4,559,625.00 $ 1,459.080  Million 320 
Xeris Biopharma Holdings Inc   4,489,923.08 $ 291.845  Million 65 
Novo Nordisk A  4,446,644.13 $ 309,064.000  Million 69,505 
Community Health Systems Inc   4,027,419.35 $ 12,485.000  Million 3,100 
Aytu Biopharma Inc  3,866,875.00 $ 61.870  Million 16 
Xoma Royalty Corporation  3,724,928.57 $ 52.149  Million 14 
Vaxart Inc   3,650,123.08 $ 237.258  Million 65 
Compugen Ltd  3,464,952.38 $ 72.764  Million 21 
Galapagos Nv  3,412,925.37 $ 1,245.718  Million 365 
Illumina Inc   3,392,968.75 $ 4,343.000  Million 1,280 
Keros Therapeutics Inc   3,304,948.72 $ 257.786  Million 78 
Halozyme Therapeutics Inc   3,301,680.85 $ 1,396.611  Million 423 
Catalyst Pharmaceuticals Inc   3,236,203.30 $ 588.989  Million 182 
Therapeuticsmd Inc   3,022,000.00 $ 3.022  Million 1 
Harmony Biosciences Holdings inc   2,962,836.18 $ 868.111  Million 293 
Ironwood Pharmaceuticals inc   2,961,510.00 $ 296.151  Million 100 
Amgen Inc   2,827,000.00 $ 36,751.000  Million 13,000 
Spero Therapeutics Inc   2,672,080.00 $ 66.802  Million 25 
Sarepta Therapeutics Inc   2,632,619.16 $ 2,198.237  Million 835 
Grifols Sa  2,622,745.10 $ 8,426.880  Million 3,213 
Innoviva Inc   2,419,289.31 $ 384.667  Million 159 
United Therapeutics Corporation  2,273,357.14 $ 3,182.700  Million 1,400 
Anaptysbio Inc   2,255,798.08 $ 234.603  Million 104 
Assertio Holdings inc   2,239,867.92 $ 118.713  Million 53 
Aurinia Pharmaceuticals Inc   2,211,367.19 $ 283.055  Million 128 
Elite Pharmaceuticals Inc   2,131,496.71 $ 138.547  Million 65 
Exelixis Inc   2,022,777.68 $ 2,320.126  Million 1,147 
Biocryst Pharmaceuticals Inc   2,011,119.54 $ 874.837  Million 435 
Prestige Consumer Healthcare Inc   1,935,594.74 $ 1,103.289  Million 570 
Siga Technologies Inc  1,930,100.04 $ 94.575  Million 49 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.